Home › Lupus Nephritis › California › San Francisco
Lupus Nephritis clinical trials in San Francisco, CA
7 studies for Lupus Nephritis are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
VIBRANT: VIB4920 for Active Lupus Nephritis
RecruitingPhase 2
- University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center, San Francisco
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
RecruitingPhase 1
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
RecruitingPhase 2
- University of California, San Francisco, San Francisco
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
RecruitingPhase 2
- University of California San Francisco, San Francisco
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RecruitingPhase 1/2
- Research Site, San Francisco
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
RecruitingPhase 2
- UCSF Benioff Childrens Hospital, San Francisco
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- University of California San Francisco, San Francisco
Lupus Nephritis trials in other cities
- New York City, NY10 studies
- Chicago, IL9 studies
- Atlanta, GA9 studies
- Houston, TX8 studies
- Durham, NC8 studies
- Boston, MA7 studies
- Philadelphia, PA7 studies
- Aurora, CO5 studies
- Miami, FL5 studies
- St. Louis, MO5 studies
- Cleveland, OH4 studies
- Los Angeles, CA4 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.